Resting Heart Rate and Long-Term Outcomes in Patients with Percutaneous Coronary Intervention: Results from a 10-Year Follow-Up of the CORFCHD-PCI Study

Table 3

Multivariable Cox regression analysis of ACM.

Variables	B	SE	Wald	values	HR (95% CI)
Age	0.021	0.006	12.362	<0.001	1.021 (1.009–1.032)
SBP	−0.004	0.004	1.218	0.270	0.996 (0.988–1.003)
DBP	−0.001	0.006	0.045	0.832	0.999 (0.986–1.011)
Diabetes	0.049	0.147	0.112	0.737	1.051 (0.787–1.402)
Hypertension	0.162	0.132	1.490	0.222	1.175 (0.907–1.524)
ML	0.481	0.136	12.487	<0.001	1.618 (1.239–2.112)
CTO	0.288	0.145	3.962	0.047	1.333 (1.004–1.770)
Aspirin	−1.955	0.203	92.801	<0.001	0.142 (0.095–0.211)
Statins	−1.008	0.232	18.879	<0.001	0.365 (0.232–0.575)
β-Blockers	−0.905	0.237	14.624	<0.001	0.405 (0.254–0.643)
LVEDD	−0.015	0.012	1.579	0.209	0.985 (0.962–1.008)
LVEF	−0.006	0.009	0.354	0.552	0.994 (0.976–1.013)
Heart rate (<66 beats/min as reference)			21.329	<0.001
66–72 beats/min	0.124	0.236	0.275	0.600	1.132 (0.713–1.796)
72–78 beats/min	0.112	0.214	0.274	0.601	1.119 (0.735–1.703)
78–84 beats/min	0.583	0.201	8.388	0.004	1.791 (1.207–2.657)
≥84 beats/min	0.686	0.199	11.849	0.001	1.987 (1.344–2.937)